zolpidem has been researched along with Catatonia in 13 studies
Zolpidem: An imidazopyridine derivative and short-acting GABA-A receptor agonist that is used for the treatment of INSOMNIA.
zolpidem : An imidazo[1,2-a]pyridine compound having a 4-tolyl group at the 2-position, an N,N-dimethylcarbamoylmethyl group at the 3-position and a methyl substituent at the 6-position.
Catatonia: A neuropsychiatric disorder characterized by one or more of the following essential features: immobility, mutism, negativism (active or passive refusal to follow commands), mannerisms, stereotypies, posturing, grimacing, excitement, echolalia, echopraxia, muscular rigidity, and stupor; sometimes punctuated by sudden violent outbursts, panic, or hallucinations. This condition may be associated with psychiatric illnesses (e.g., SCHIZOPHRENIA; MOOD DISORDERS) or organic disorders (NEUROLEPTIC MALIGNANT SYNDROME; ENCEPHALITIS, etc.). (From DSM-IV, 4th ed, 1994; APA, Thesaurus of Psychological Index Terms, 1994)
| Excerpt | Relevance | Reference |
|---|---|---|
| "There is no consensus regarding treatment of catatonia and the main recent therapeutic progress has been the development of the zolpidem diagnostic and therapeutic test." | 7.81 | Zolpidem test and catatonia. ( Cottencin, O; Javelot, H; Javelot, T; Michel, B; Steiner, R, 2015) |
| "Catatonia is a complication of numerous psychiatric and medical conditions." | 5.91 | Rapid resolution of catatonia secondary to post traumatic stress disorder with secondary psychotic features through scheduled zolpidem tartrate. ( Bonomo, N; Huang, H; Schoenbachler, B, 2023) |
| "Psychiatric symptoms and catatonia are key components of the clinical presentation of paraneoplastic encephalitis; additionally symptoms can be long-lasting and often difficult to treat." | 5.43 | Rapidly-progressive catatonia responsive to zolpidem in a patient with ovarian teratoma-associated paraneoplastic encephalitis. ( Amorim, E; McDade, EM, 2016) |
| "Treatment with zolpidem led to durable improvement." | 5.29 | [Favourable effect of zolpidem on catatonia]. ( Guerouaou, D; Mastain, B; Pommery, J; Thomas, P; Vaiva, G, 1995) |
| "There is no consensus regarding treatment of catatonia and the main recent therapeutic progress has been the development of the zolpidem diagnostic and therapeutic test." | 3.81 | Zolpidem test and catatonia. ( Cottencin, O; Javelot, H; Javelot, T; Michel, B; Steiner, R, 2015) |
| "Though catatonia is common and highly treatable, there have been few research studies investigating the syndrome." | 2.45 | Catatonia: clinical aspects and neurobiological correlates. ( Daniels, J, 2009) |
| "Catatonia is a complication of numerous psychiatric and medical conditions." | 1.91 | Rapid resolution of catatonia secondary to post traumatic stress disorder with secondary psychotic features through scheduled zolpidem tartrate. ( Bonomo, N; Huang, H; Schoenbachler, B, 2023) |
| "Psychiatric symptoms and catatonia are key components of the clinical presentation of paraneoplastic encephalitis; additionally symptoms can be long-lasting and often difficult to treat." | 1.43 | Rapidly-progressive catatonia responsive to zolpidem in a patient with ovarian teratoma-associated paraneoplastic encephalitis. ( Amorim, E; McDade, EM, 2016) |
| "The zolpidem test is a useful diagnostic and therapeutic test." | 1.35 | Catatonia recognition and treatment. ( Consoli, SM; Cottencin, O; Danel, T; Goudemand, M; Thomas, P, 2009) |
| "The presentation of catatonia in autism and the use of ECT in children are discussed, and the available literature reviewed." | 1.30 | Catatonia, autism, and ECT. ( Bates, GD; Bentham, P; Murali, V; Zaw, FK, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (30.77) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 4 (30.77) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Bonomo, N | 1 |
| Huang, H | 1 |
| Schoenbachler, B | 1 |
| Spiegel, DR | 1 |
| Ahuja, K | 1 |
| Reid, FE | 1 |
| Hegde, S | 1 |
| Carbaugh, E | 1 |
| Tran, V | 1 |
| Forte, S | 1 |
| Strauss, E | 1 |
| Lagbo, J | 1 |
| Lau, J | 1 |
| Peglow, S | 1 |
| Prem, V | 1 |
| McDaniel, W | 1 |
| Bastiampillai, T | 1 |
| McGovern, V | 1 |
| Lloyd, B | 1 |
| Hittur Lingappa, S | 1 |
| Nelson, A | 1 |
| Javelot, H | 1 |
| Michel, B | 1 |
| Steiner, R | 1 |
| Javelot, T | 1 |
| Cottencin, O | 2 |
| Amorim, E | 1 |
| McDade, EM | 1 |
| Danel, T | 1 |
| Goudemand, M | 1 |
| Thomas, P | 3 |
| Consoli, SM | 1 |
| Daniels, J | 1 |
| Seetharam, P | 1 |
| Akerman, RR | 1 |
| Mastain, B | 2 |
| Vaiva, G | 2 |
| Guerouaou, D | 1 |
| Pommery, J | 1 |
| Rascle, C | 1 |
| Maron, M | 1 |
| Zaw, ZF | 1 |
| Bates, GD | 2 |
| Zaw, FK | 1 |
| Murali, V | 1 |
| Bentham, P | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Use of Electroconvulsive Therapy to Treat Self-Injurious Behavior in Adults With Autism Spectrum Disorders[NCT03980366] | 1 participants (Actual) | Interventional | 2019-03-15 | Terminated (stopped due to We have not obtained additional subjects and chose to terminate/close this study.) | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for zolpidem and Catatonia
| Article | Year |
|---|---|
Catatonia: clinical aspects and neurobiological correlates.
Topics: Benzodiazepines; Brain; Catatonia; Combined Modality Therapy; Electroconvulsive Therapy; Humans; Pyr | 2009 |
12 other studies available for zolpidem and Catatonia
| Article | Year |
|---|---|
Rapid resolution of catatonia secondary to post traumatic stress disorder with secondary psychotic features through scheduled zolpidem tartrate.
Topics: Benzodiazepines; Catatonia; Electroconvulsive Therapy; Female; Humans; Psychotic Disorders; Stress D | 2023 |
A Case of Ovarian Teratoma-Induced N-Methyl-D-Aspartate Receptor Antibody Encephalitis Presenting With Psychosis and Catatonia, Progressing to the Minimally Conscious State and Successfully Treated With Adjunctive Zolpidem.
Topics: Anti-N-Methyl-D-Aspartate Receptor Encephalitis; Autoantibodies; Catatonia; Encephalitis; Female; Hu | 2023 |
Treatment of catatonia with zolpidem.
Topics: Catatonia; Humans; Hypnotics and Sedatives; Male; Middle Aged; Pyridines; Zolpidem | 2013 |
Treatment refractory chronic catatonia responsive to zolpidem challenge.
Topics: Bipolar Disorder; Catatonia; Female; GABA-A Receptor Agonists; Humans; Middle Aged; Pyridines; Zolpi | 2016 |
Zolpidem test and catatonia.
Topics: Adult; Antipsychotic Agents; Catatonia; Humans; Male; Pyridines; Schizophrenia, Paranoid; Zolpidem | 2015 |
Rapidly-progressive catatonia responsive to zolpidem in a patient with ovarian teratoma-associated paraneoplastic encephalitis.
Topics: Aged; Catatonia; Disease Progression; Female; Humans; Hypnotics and Sedatives; Ovarian Neoplasms; Pa | 2016 |
Catatonia recognition and treatment.
Topics: Catatonia; Female; Humans; Middle Aged; Psychiatric Status Rating Scales; Pyridines; Zolpidem | 2009 |
Postoperative echolalia and catatonia responsive to gamma aminobutyric acid receptor agonists in a liver transplant patient.
Topics: Benzodiazepines; Catatonia; Echolalia; GABA Agonists; Humans; Liver Transplantation; Male; Middle Ag | 2006 |
[Favourable effect of zolpidem on catatonia].
Topics: Catatonia; Dopamine; Female; Humans; Hypnotics and Sedatives; Middle Aged; Pyridines; Receptors, GAB | 1995 |
Test for catatonia with zolpidem.
Topics: Administration, Oral; Adult; Alprazolam; Catatonia; Female; Humans; Hypnotics and Sedatives; Pyridin | 1997 |
Replication of zolpidem test for catatonia in an adolescent.
Topics: Adolescent; Autistic Disorder; Catatonia; Humans; Hypnotics and Sedatives; Male; Pyridines; Zolpidem | 1997 |
Catatonia, autism, and ECT.
Topics: Adolescent; Autistic Disorder; Catatonia; Combined Modality Therapy; Depressive Disorder; Disease Pr | 1999 |